The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Levosulpiride-Global Market Insights and Sales Trends 2025
Synopsis
Levosulpiride is a substituted benzamide antipsychotic.
The global Levosulpiride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Levosulpiride in various end use industries. The expanding demands from the Tablet, Capsule and Other, are propelling Levosulpiride market. Above 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Below 98% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Levosulpiride market, driven by demand from China, the second largest economy with some signs of stabilising, the Levosulpiride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Levosulpiride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Levosulpiride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Levosulpiride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Levosulpiride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Levosulpiride covered in this report include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc.
The global Levosulpiride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Global Levosulpiride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Levosulpiride market, Segment by Type:
Above 98%
Below 98%
Global Levosulpiride market, by Application
Tablet
Capsule
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Levosulpiride is a substituted benzamide antipsychotic.
The global Levosulpiride market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Levosulpiride in various end use industries. The expanding demands from the Tablet, Capsule and Other, are propelling Levosulpiride market. Above 98%, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Below 98% segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Levosulpiride market, driven by demand from China, the second largest economy with some signs of stabilising, the Levosulpiride market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Levosulpiride, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Levosulpiride market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Levosulpiride market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Levosulpiride sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Levosulpiride covered in this report include Sun Pharmaceutical Industries, Vasoya Industries, Bona Chemical, New Donghai Pharmaceutical, Suzhou Chenghe Pharmaceutical & Chemical and Harbin Gloria Pharmaceuticals, etc.
The global Levosulpiride market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sun Pharmaceutical Industries
Vasoya Industries
Bona Chemical
New Donghai Pharmaceutical
Suzhou Chenghe Pharmaceutical & Chemical
Harbin Gloria Pharmaceuticals
Global Levosulpiride market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Levosulpiride market, Segment by Type:
Above 98%
Below 98%
Global Levosulpiride market, by Application
Tablet
Capsule
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Levosulpiride manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Levosulpiride in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Levosulpiride Market Overview
1.1 Levosulpiride Product Overview
1.2 Levosulpiride Market Segment by Type
1.2.1 Above 98%
1.2.2 Below 98%
1.3 Global Levosulpiride Market Size by Type
1.3.1 Global Levosulpiride Market Size Overview by Type (2018-2029)
1.3.2 Global Levosulpiride Historic Market Size Review by Type (2018-2023)
1.3.3 Global Levosulpiride Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Levosulpiride Sales Breakdown by Type (2018-2023)
1.4.2 Europe Levosulpiride Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Levosulpiride Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Levosulpiride Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Levosulpiride Sales Breakdown by Type (2018-2023)
2 Global Levosulpiride Market Competition by Company
2.1 Global Top Players by Levosulpiride Sales (2018-2023)
2.2 Global Top Players by Levosulpiride Revenue (2018-2023)
2.3 Global Top Players by Levosulpiride Price (2018-2023)
2.4 Global Top Manufacturers Levosulpiride Manufacturing Base Distribution, Sales Area, Product Type
2.5 Levosulpiride Market Competitive Situation and Trends
2.5.1 Levosulpiride Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Levosulpiride Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Levosulpiride as of 2022)
2.7 Date of Key Manufacturers Enter into Levosulpiride Market
2.8 Key Manufacturers Levosulpiride Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Levosulpiride Status and Outlook by Region
3.1 Global Levosulpiride Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Levosulpiride Historic Market Size by Region
3.2.1 Global Levosulpiride Sales in Volume by Region (2018-2023)
3.2.2 Global Levosulpiride Sales in Value by Region (2018-2023)
3.2.3 Global Levosulpiride Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Levosulpiride Forecasted Market Size by Region
3.3.1 Global Levosulpiride Sales in Volume by Region (2024-2029)
3.3.2 Global Levosulpiride Sales in Value by Region (2024-2029)
3.3.3 Global Levosulpiride Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Levosulpiride by Application
4.1 Levosulpiride Market Segment by Application
4.1.1 Tablet
4.1.2 Capsule
4.1.3 Other
4.2 Global Levosulpiride Market Size by Application
4.2.1 Global Levosulpiride Market Size Overview by Application (2018-2029)
4.2.2 Global Levosulpiride Historic Market Size Review by Application (2018-2023)
4.2.3 Global Levosulpiride Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Levosulpiride Sales Breakdown by Application (2018-2023)
4.3.2 Europe Levosulpiride Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Levosulpiride Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Levosulpiride Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Levosulpiride Sales Breakdown by Application (2018-2023)
5 North America Levosulpiride by Country
5.1 North America Levosulpiride Historic Market Size by Country
5.1.1 North America Levosulpiride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Levosulpiride Sales in Volume by Country (2018-2023)
5.1.3 North America Levosulpiride Sales in Value by Country (2018-2023)
5.2 North America Levosulpiride Forecasted Market Size by Country
5.2.1 North America Levosulpiride Sales in Volume by Country (2024-2029)
5.2.2 North America Levosulpiride Sales in Value by Country (2024-2029)
6 Europe Levosulpiride by Country
6.1 Europe Levosulpiride Historic Market Size by Country
6.1.1 Europe Levosulpiride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Levosulpiride Sales in Volume by Country (2018-2023)
6.1.3 Europe Levosulpiride Sales in Value by Country (2018-2023)
6.2 Europe Levosulpiride Forecasted Market Size by Country
6.2.1 Europe Levosulpiride Sales in Volume by Country (2024-2029)
6.2.2 Europe Levosulpiride Sales in Value by Country (2024-2029)
7 Asia-Pacific Levosulpiride by Region
7.1 Asia-Pacific Levosulpiride Historic Market Size by Region
7.1.1 Asia-Pacific Levosulpiride Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Levosulpiride Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Levosulpiride Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Levosulpiride Forecasted Market Size by Region
7.2.1 Asia-Pacific Levosulpiride Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Levosulpiride Sales in Value by Region (2024-2029)
8 Latin America Levosulpiride by Country
8.1 Latin America Levosulpiride Historic Market Size by Country
8.1.1 Latin America Levosulpiride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Levosulpiride Sales in Volume by Country (2018-2023)
8.1.3 Latin America Levosulpiride Sales in Value by Country (2018-2023)
8.2 Latin America Levosulpiride Forecasted Market Size by Country
8.2.1 Latin America Levosulpiride Sales in Volume by Country (2024-2029)
8.2.2 Latin America Levosulpiride Sales in Value by Country (2024-2029)
9 Middle East and Africa Levosulpiride by Country
9.1 Middle East and Africa Levosulpiride Historic Market Size by Country
9.1.1 Middle East and Africa Levosulpiride Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Levosulpiride Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Levosulpiride Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Levosulpiride Forecasted Market Size by Country
9.2.1 Middle East and Africa Levosulpiride Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Levosulpiride Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sun Pharmaceutical Industries
10.1.1 Sun Pharmaceutical Industries Company Information
10.1.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.1.3 Sun Pharmaceutical Industries Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sun Pharmaceutical Industries Levosulpiride Products Offered
10.1.5 Sun Pharmaceutical Industries Recent Development
10.2 Vasoya Industries
10.2.1 Vasoya Industries Company Information
10.2.2 Vasoya Industries Introduction and Business Overview
10.2.3 Vasoya Industries Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Vasoya Industries Levosulpiride Products Offered
10.2.5 Vasoya Industries Recent Development
10.3 Bona Chemical
10.3.1 Bona Chemical Company Information
10.3.2 Bona Chemical Introduction and Business Overview
10.3.3 Bona Chemical Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bona Chemical Levosulpiride Products Offered
10.3.5 Bona Chemical Recent Development
10.4 New Donghai Pharmaceutical
10.4.1 New Donghai Pharmaceutical Company Information
10.4.2 New Donghai Pharmaceutical Introduction and Business Overview
10.4.3 New Donghai Pharmaceutical Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.4.4 New Donghai Pharmaceutical Levosulpiride Products Offered
10.4.5 New Donghai Pharmaceutical Recent Development
10.5 Suzhou Chenghe Pharmaceutical & Chemical
10.5.1 Suzhou Chenghe Pharmaceutical & Chemical Company Information
10.5.2 Suzhou Chenghe Pharmaceutical & Chemical Introduction and Business Overview
10.5.3 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Suzhou Chenghe Pharmaceutical & Chemical Levosulpiride Products Offered
10.5.5 Suzhou Chenghe Pharmaceutical & Chemical Recent Development
10.6 Harbin Gloria Pharmaceuticals
10.6.1 Harbin Gloria Pharmaceuticals Company Information
10.6.2 Harbin Gloria Pharmaceuticals Introduction and Business Overview
10.6.3 Harbin Gloria Pharmaceuticals Levosulpiride Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Harbin Gloria Pharmaceuticals Levosulpiride Products Offered
10.6.5 Harbin Gloria Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Levosulpiride Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Levosulpiride Industrial Chain Analysis
11.4 Levosulpiride Market Dynamics
11.4.1 Levosulpiride Industry Trends
11.4.2 Levosulpiride Market Drivers
11.4.3 Levosulpiride Market Challenges
11.4.4 Levosulpiride Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Levosulpiride Distributors
12.3 Levosulpiride Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
